Company profile for Sirona Biochem Corp

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Sirona Biochem was founded in 2009 by its current Chairman and CEO, Dr. Howard Verrico. The Company’s first transaction was to acquire an exclusive global license to TFChem’s proprietary diabetes drug, the SGLT2 Inhibitor. In 2011, Sirona Biochem went on to acquire TFChem’s entire platform and development laboratory in Rouen, France. As a result of the transaction, the founder of TFChem, Dr. Geraldine Deliencourt-Godefro...
Sirona Biochem was founded in 2009 by its current Chairman and CEO, Dr. Howard Verrico. The Company’s first transaction was to acquire an exclusive global license to TFChem’s proprietary diabetes drug, the SGLT2 Inhibitor. In 2011, Sirona Biochem went on to acquire TFChem’s entire platform and development laboratory in Rouen, France. As a result of the transaction, the founder of TFChem, Dr. Geraldine Deliencourt-Godefroy, became the largest shareholder and Chief Scientific Officer of Sirona Biochem.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
595 Burrard St Vancouver, British Columbia V7X 1L4, CA
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/08/01/3126116/0/en/Sirona-Biochem-Update-to-Shareholders-on-Financial-Status-and-Operations.html

GLOBENEWSWIRE
01 Aug 2025

https://www.globenewswire.com/news-release/2025/04/22/3065825/0/en/Sirona-Biochem-Announces-Debenture-Financing.html

GLOBENEWSWIRE
22 Apr 2025

https://www.globenewswire.com/news-release/2025/04/22/3065172/0/en/Sirona-Biochem-Secures-Strategic-Investment-Agreements-and-New-Joint-Venture-with-Promura-GmbH.html

GLOBENEWSWIRE
22 Apr 2025

https://www.globenewswire.com/news-release/2025/01/15/3010348/0/en/Sirona-Biochem-Showcases-TFC-1326-in-Stonegate-Healthcare-s-Landmark-Report.html

GLOBENEWSWIRE
15 Jan 2025

https://www.globenewswire.com/news-release/2024/11/20/2984794/0/en/Sirona-Biochem-Announces-Publication-of-Groundbreaking-Study-on-TFC-1326-Compound-in-the-Journal-of-Cosmetic-Dermatology.html

GLOBENEWSWIRE
20 Nov 2024

https://www.globenewswire.com/news-release/2024/09/25/2952986/0/en/SIRONA-BIOCHEM-Poised-for-Profitability-in-2025-with-Anti-Aging-Product-Rollout.html

GLOBENEWSWIRE
25 Sep 2024

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty